Clinithink
company
About
Clinithink offers cloud-based text processing capability to support data analytics, coding, and decision support in healthcare applications.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Analytics,Artificial Intelligence,Clinical Trials,Health Care,Information Services,Information Technology,Life Science,Software
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Clinithink, a London, UK-based healthcare software company. Led by CEO Chris Tackaberry, Clinithink has developed cloud-based text processing capability that can be used to support data analytics, coding and decision support in healthcare applications. Its patent-pending Clinical Language Indexing software (CLiX) uses Natural Language Processing (NLP) to construct coded output from physicians’ notes using industry data standards (ICD-9, ICD-10, and SNOMED CT).
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
Clinithink has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Mar 3, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 3, 2019 | Series B | — | 1 |
Merck
|
— | Detail |
| Apr 20, 2012 | Series A | — | 1 |
Vanguard Atlantic
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Clinithink is funded by 2 investors.
Merck
and Vanguard Atlantic
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Merck
|
Yes | Series B |
|
Vanguard Atlantic
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
